Back to search
Breast Cancer With Low to Intermediate HER2 Expression
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Breast Cancer With Low to Intermediate HER2 Expression trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Breast Cancer With Low to Intermediate HER2 Expression trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
The purpose of this study is to determine whether a personalized, risk-stratified surveillance strategy can safely reduce unnecessary cardiac imaging while pres…
Cancer continues to be one of the most significant public health issues worldwide. Thanks to early detection, the mortality rate of certain types of cancer has…
In addition to TNM staging, the current management of breast cancer is based on conventional pathological features that categorize the disease into three molecu…
Purpose of this trial: 1. To assess the efficacy and safety of NeuVax™ administered with adjuvant Leukine® (sargramostim, GM-CSF). 2. To evaluate and compare t…